Vancouver, BC – January 21, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need… Read More
Vancouver, BC – January 20, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs,… Read More
VANCOUVER, British Columbia–(BUSINESS WIRE)–Chinook Therapeutics, Inc., a biotechnology company focused on developing precision medicines for kidney diseases, today announced it has entered into a license agreement with AbbVie, a research-based… Read More
VANCOUVER, January 16, 2020 /CNW/ — InMed Pharmaceuticals Inc. (“InMed” or “the Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs,… Read More
TORRANCE, Calif., Jan. 13, 2020 /PRNewswire/ — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation and a leader in diagnostic medical imaging systems, along with NZ Technologies of Vancouver Canada and developers of TIPSOTM technology, today… Read More
